Intrathecal Rituximab in Progressive Multiple Sclerosis

Clinical trial NCT02545959 · COMPLETED

Trial details

NCT number: NCT02545959
Sponsor: Centre Hospitalier de PAU
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis, Chronic Progressive Nervous System Diseases

Start date: 2015-11-30
Primary completion: 2019-02-22
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.